Use of zoledronic acid in the treatment of Paget’s disease

This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Seton, Margaret, Krane, Stephen M
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376069/
https://www.ncbi.nlm.nih.gov/pubmed/18473015
_version_ 1782154684033662976
author Seton, Margaret
Krane, Stephen M
author_facet Seton, Margaret
Krane, Stephen M
author_sort Seton, Margaret
collection PubMed
description This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bone by the more potent bisphosphonates and their association with avascular necrosis of the jaw are noted.
format Text
id pubmed-2376069
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-23760692008-05-12 Use of zoledronic acid in the treatment of Paget’s disease Seton, Margaret Krane, Stephen M Ther Clin Risk Manag Review This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bone by the more potent bisphosphonates and their association with avascular necrosis of the jaw are noted. Dove Medical Press 2007-10 2007-10 /pmc/articles/PMC2376069/ /pubmed/18473015 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Seton, Margaret
Krane, Stephen M
Use of zoledronic acid in the treatment of Paget’s disease
title Use of zoledronic acid in the treatment of Paget’s disease
title_full Use of zoledronic acid in the treatment of Paget’s disease
title_fullStr Use of zoledronic acid in the treatment of Paget’s disease
title_full_unstemmed Use of zoledronic acid in the treatment of Paget’s disease
title_short Use of zoledronic acid in the treatment of Paget’s disease
title_sort use of zoledronic acid in the treatment of paget’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376069/
https://www.ncbi.nlm.nih.gov/pubmed/18473015
work_keys_str_mv AT setonmargaret useofzoledronicacidinthetreatmentofpagetsdisease
AT kranestephenm useofzoledronicacidinthetreatmentofpagetsdisease

Ejemplares similares